Effects of intravitreal bevacizumab in Gram-positive and Gram-negative models of ocular inflammation

J. Daniel Lafreniere; James T. Toguri; Rishi R. Gupta; Arif Samad; Dan M. O'Brien; John Dickinson; Alan Cruess; Melanie E.M. Kelly; Mark E. Seamone

doi:10.1111/ceo.13453

Effects of intravitreal bevacizumab in Gram-positive and Gram-negative models of ocular inflammation

J. Daniel Lafreniere, James T. Toguri, Rishi R. Gupta, Arif Samad, Dan M. O'Brien, John Dickinson, Alan Cruess, Melanie E.M. Kelly, Mark E. Seamone

科研成果: 期刊稿件 › 文章 › 同行评审

10 引用（Scopus）

源语言	英语
页（从-至）	638-645
页数	8
期刊	Clinical and Experimental Ophthalmology
卷	47
期	5
DOI	https://doi.org/10.1111/ceo.13453
出版状态	已出版 - 7月 2019
已对外发布	是

!!!ASJC Scopus Subject Areas

眼科学

访问文件

10.1111/ceo.13453

其它文件与链接

引用此

@article{67c6578d6068496c9f753d32d06d3c0c,

title = "Effects of intravitreal bevacizumab in Gram-positive and Gram-negative models of ocular inflammation",

keywords = "bevacizumab, lipopolysaccharide, ocular inflammation, peptidoglycan, vascular endothelial growth factor a",

author = "Lafreniere, {J. Daniel} and Toguri, {James T.} and Gupta, {Rishi R.} and Arif Samad and O'Brien, {Dan M.} and John Dickinson and Alan Cruess and Kelly, {Melanie E.M.} and Seamone, {Mark E.}",

note = "Publisher Copyright: {\textcopyright} 2018 Royal Australian and New Zealand College of Ophthalmologists",

year = "2019",

month = jul,

doi = "10.1111/ceo.13453",

language = "English",

volume = "47",

pages = "638--645",

journal = "Clinical and Experimental Ophthalmology",

issn = "1442-6404",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Effects of intravitreal bevacizumab in Gram-positive and Gram-negative models of ocular inflammation

AU - Lafreniere, J. Daniel

AU - Toguri, James T.

AU - Gupta, Rishi R.

AU - Samad, Arif

AU - O'Brien, Dan M.

AU - Dickinson, John

AU - Cruess, Alan

AU - Kelly, Melanie E.M.

AU - Seamone, Mark E.

PY - 2019/7

Y1 - 2019/7

KW - bevacizumab

KW - lipopolysaccharide

KW - ocular inflammation

KW - peptidoglycan

KW - vascular endothelial growth factor a

UR - http://www.scopus.com/inward/record.url?scp=85059470139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059470139&partnerID=8YFLogxK

U2 - 10.1111/ceo.13453

DO - 10.1111/ceo.13453

M3 - Article

C2 - 30485637

AN - SCOPUS:85059470139

SN - 1442-6404

VL - 47

SP - 638

EP - 645

JO - Clinical and Experimental Ophthalmology

JF - Clinical and Experimental Ophthalmology

IS - 5

ER -

Effects of intravitreal bevacizumab in Gram-positive and Gram-negative models of ocular inflammation

!!!ASJC Scopus Subject Areas

访问文件

其它文件与链接

指纹

引用此